Trospium is an antispasmodic agent used to treat the symptoms of overactive bladder, a condition that causes the bladder muscles to contract uncontrollably. An overactive bladder leads to an increased urge to urinate, frequent urination, and sometimes, loss of control over urination. Trospium is manufactured by Indevus Pharmaceutical Inc. and was granted FDA approval in 2007. It is grouped under the following drug class(es): Anticholinergics and Overactive bladder agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Regurin and Flotros. Its PubChem CID is 5284632.
Trospium
| CAS No | 47608-32-2 |
|---|---|
| Molecular Formula | C25H30NO3+ |
| Molecular Weight | 392.5 g/mol |
| Synonyms | [(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1′-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trospium is an antispasmodic agent used to treat the symptoms of overactive bladder, a condition that causes the bladder muscles to contract uncontrollably. An overactive bladder leads to an increased urge to urinate, frequent urination, and sometimes, loss of control over urination.
The listed CAS number is 47608-32-2.
The listed molecular formula is C25H30NO3+.
The listed molecular weight is 392.5 g/mol.
[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1′-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate.
The source lists Regurin and Flotros.